-
Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.
-
The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.
-
The Tulsa Opera partnered with a national program called Songs By Heart to bring interactive music therapy to the memory care community.
-
Researchers found diagnosis rates varied depending on location — with parts of the Great Plains and Southwest seeing fewer dementia cases than predicted.
-
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
-
Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer's and other threats to memory and thinking.
-
Advisers to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.
-
A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
-
Biomarker testing is a tool that doctors use to get a clearer picture of a medical problem — often cancer.
-
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.